The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Research and Evaluation in Safety, Health, and Wellness in the Criminal Justice System, FY 2019 |
16.560 |
NIJ-2019-15283 |
| Rehabilitation Research and Training Center (RRTC) on Health and Function of People with Physical Disabilities |
93.433 |
HHS-2019-ACL-NIDILRR-RTHF-0335 |
| Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed) |
93.286 |
PAR-19-215 |
| Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) |
93.242 |
PAR-19-214 |
| Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) |
93.273, 93.279 |
PAR-19-213 |
| Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) |
93.273, 93.279 |
PAR-19-212 |
| Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed) |
93.853, 93.866 |
PAS-19-210 |
| Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed) |
93.853, 93.866 |
RFA-NS-19-015 |
| Military Medical Photonics Program |
12.420 |
FA9550-19-S-0002 |
| Disability and Rehabilitation Research Projects (DRRP) Program: Projects for Translating the Findings and Products of Disability and Rehabilitation Research and Development into Practice |
93.433 |
HHS-2019-ACL-NIDILRR-DPKT-0332 |
| Announcement of the Availability of Funds for Research on Research Integrity |
93.085 |
IR-ORI-19-001 |
| Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-19-028 |
| Emerging Infectious Diseases Research Centers - Coordination Center (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-19-029 |
| Geroscience Approaches to Alzheimer's Disease (R21 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-014 |
| Geroscience Approaches to Alzheimer's Disease (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-013 |
| Preventing Maternal Deaths: Supporting Maternal Mortality Review Committees |
93.478 |
CDC-RFA-DP19-1908 |
| Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) |
93.855 |
PAR-19-209 |
| Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed) |
93.273, 93.279 |
PAR-19-207 |
| Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24 Clinical Trial Not Allowed) |
93.859 |
PAR-19-208 |
| Technical Assistance to Increase Tobacco Cessation |
93.348 |
CDC-RFA-DP19-1904 |
| FY 2019 SBIR/STTR Phase II Release 2 |
81.049 |
DE-FOA-0001976 |
| Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY19 Administrative Supplement (Admin Supp Clinical Trial Optional) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.847, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879 |
PA-19-205 |
| Interventions Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-19-031 |
| BJA FY 19 National Sexual Assault Kit Initiative (SAKI) Training and Technical Assistance |
16.833 |
BJA-2019-15229 |
| FY19 High Priority-Commercial Motor Vehicle Grant Program (HP-CMV) |
20.237 |
FM-MHP-19-001 |
| Research on Immigration and Crime, FY 2019 |
16.560 |
NIJ-2019-15588 |
| Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) |
93.121, 93.213, 93.233, 93.273, 93.279, 93.313, 93.361, 93.393, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866 |
PA-19-200 |
| Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) |
93.121, 93.213, 93.273, 93.279, 93.313, 93.361, 93.393, 93.853, 93.866 |
PA-19-201 |
| Centers of Excellence in Genomic Science (RM1 Clinical Trials Optional) |
93.172, 93.242 |
PAR-19-204 |
| Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) |
93.393, 93.396 |
PAR-19-199 |
| Measuring the Impact of Victim Services: Instrument Development, FY 2019 |
16.560 |
NIJ-2019-15594 |
| Rhinoceros and Tiger Conservation Fund - AFRICA |
15.619 |
F19AS00111 |
| High impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) |
93.847 |
PAR-19-202 |
| Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) |
93.393, 93.396 |
PAR-19-198 |
| Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Medicines (R21 Clinical Trial Not Allowed) |
93.242 |
RFA-MH-20-115 |
| Evaluations of Services for Victims of Crime, FY 2019 |
16.560 |
NIJ-2019-15443 |
| DRL Democracy, Human Rights, and Rule of Law in Iraq |
19.016 |
SFOP0005572 |
| Research and Evaluation on Trafficking in Persons, FY 2019 |
16.560 |
NIJ-2019-15231 |
| Advancing Post-Market Surveillance of High-Risk Facilities and Products through Signal detection, Data analysis, and the Review of the State of Quality (U01) Clinical Trial Optional |
93.103 |
PAR-19-190 |
| Investigator-Initiated Research and Evaluation on Firearm Violence, FY 2019 |
16.560 |
NIJ-2019-15288 |
Search Results 5761-5800 of 21019
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 [Next] |
